AIDX · NASDAQ
20/20 Biolabs (AIDX) Stock Price & Fundamentals
20/20 Biolabs (AIDX) closed at $143.84 on Oct 9, 2026, down 1.30% from the previous close of $145.74.
Share price, past year
1Y −1.53%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $143.84 |
| Sep 30, 2026 | $146.41 |
| Aug 31, 2026 | $148.43 |
| Jul 31, 2026 | $142.20 |
| Jun 30, 2026 | $141.98 |
| May 29, 2026 | $140.44 |
| Apr 30, 2026 | $137.85 |
| Mar 31, 2026 | $142.59 |
| Feb 27, 2026 | $136.92 |
| Jan 30, 2026 | $142.87 |
| Dec 31, 2025 | $150.74 |
| Nov 28, 2025 | $149.73 |
| Oct 31, 2025 | $145.97 |
Key statistics
- Market cap
- $1.76B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 12.3M
- Dividend yield
- —
- 52-week range
- $134.89 – $153.08
20/20 Biolabs's market cap is $1.76B, based on a share price of $143.84 and 12.3M shares outstanding as of Jun 30, 2026.
Financials
20/20 Biolabs reported revenue of $2.05M for fiscal 2025, up 16.71% from fiscal 2024.
20/20 Biolabs reported a net loss of $3.74M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.05M | +16.7% | −$3.74M | −182.8% | −$0.76 | — |
| FY2024ended Dec 31, 2024 | $1.75M | — | −$5.55M | −316.8% | −$1.16 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $730.57K | −$1.51M | −$0.26 |
| Q1 FY2026ended Mar 31, 2026 | $353.38K | −$2.17M | −$0.28 |
| Q2 FY2025ended Jun 30, 2025 | $535.06K | −$840.93K | −$0.17 |
| Q1 FY2025ended Mar 31, 2025 | $553.82K | −$764.58K | −$0.16 |
Company profile
- Name
- 20/20 Biolabs, Inc.
- Ticker
- AIDX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Testing Laboratories
- Headquarters
- 9430 Key West Avenue, Suite 100, Rockville, MD 20850
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001139685
Recent SEC filings
- Sep 18, 2026
- Sep 10, 2026
- Sep 2, 2026
- Aug 19, 2026
- Aug 17, 2026
- Aug 14, 2026
- Aug 5, 2026
- Jul 22, 2026
Frequently asked questions
What is 20/20 Biolabs's stock price?
20/20 Biolabs (AIDX) closed at $143.84 on Oct 9, 2026, down 1.30% from the previous close of $145.74.
What is 20/20 Biolabs's market cap?
20/20 Biolabs's market cap is $1.76B, based on a share price of $143.84 and 12.3M shares outstanding as of Jun 30, 2026.
How much revenue does 20/20 Biolabs make?
20/20 Biolabs reported revenue of $2.05M for fiscal 2025, up 16.71% from fiscal 2024.
Sources and methodology
Fundamentals come from 20/20 Biolabs, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures